haloperidol has been researched along with Cataleptic Attacks in 7 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Haloperidol was stopped and intravenous clonazepam 5mg/kg was begun." | 5.36 | [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up]. ( Askenazy, F; Benoit, M; Dor, E; Dupuis, G; Myquel, M; Seddiki, Y; Serret, S, 2010) |
| "Haloperidol was stopped and intravenous clonazepam 5mg/kg was begun." | 1.36 | [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up]. ( Askenazy, F; Benoit, M; Dor, E; Dupuis, G; Myquel, M; Seddiki, Y; Serret, S, 2010) |
| " As ciproxifan and thioperamide are inhibitors of cytochrome P450 enzymes, responsible for metabolizing risperidone and haloperidol, the possibility that the augmentation of antipsychotics by imidazoles resulted from drug-drug interactions was tested." | 1.33 | Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs. ( Ballard, ME; Cowart, M; Decker, MW; Esbenshade, TA; Faghih, R; Fox, GB; Hancock, AA; Pan, L; Roberts, S; Rueter, LE; Zhang, M, 2005) |
| "Thus, experimental cataplexy is suppressed more by inhibition of the uptake of NE than of 5-HT." | 1.26 | Monoaminergic mechanisms and experimental cataplexy. ( Delashaw, JB; Dement, WC; Foutz, AS; Guilleminault, C, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Askenazy, F | 1 |
| Dor, E | 1 |
| Benoit, M | 1 |
| Dupuis, G | 1 |
| Serret, S | 1 |
| Myquel, M | 1 |
| Seddiki, Y | 1 |
| Ossowska, K | 1 |
| Wardas, J | 1 |
| Pietraszek, M | 1 |
| Konieczny, J | 1 |
| Wolfarth, S | 1 |
| Amtage, J | 1 |
| Schmidt, WJ | 1 |
| Zhang, M | 1 |
| Ballard, ME | 1 |
| Pan, L | 1 |
| Roberts, S | 1 |
| Faghih, R | 1 |
| Cowart, M | 1 |
| Esbenshade, TA | 1 |
| Fox, GB | 1 |
| Decker, MW | 1 |
| Hancock, AA | 1 |
| Rueter, LE | 1 |
| Foutz, AS | 1 |
| Delashaw, JB | 1 |
| Guilleminault, C | 1 |
| Dement, WC | 1 |
| Olianas, MC | 1 |
| De Montis, MG | 1 |
| Mulas, G | 1 |
| Tagliamonte, A | 1 |
| Duncan, JW | 1 |
7 other studies available for haloperidol and Cataleptic Attacks
| Article | Year |
|---|---|
[Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
Topics: Acute Disease; Adolescent; Adult; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Cataplexy; C | 2010 |
The striopallidal pathway is involved in antiparkinsonian-like effects of the blockade of group I metabotropic glutamate receptors in rats.
Topics: Animals; Cataplexy; Corpus Striatum; Dopamine Antagonists; Enkephalins; Globus Pallidus; Haloperidol | 2003 |
Context-dependent catalepsy intensification is due to classical conditioning and sensitization.
Topics: Animals; Association Learning; Cataplexy; Conditioning, Classical; Corpus Striatum; Dopamine; Dopami | 2003 |
Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs.
Topics: Animals; Antipsychotic Agents; Benzofurans; Brain Chemistry; Cataplexy; Cytochrome P-450 Enzyme Syst | 2005 |
Monoaminergic mechanisms and experimental cataplexy.
Topics: Animals; Antidepressive Agents, Tricyclic; Biogenic Amines; Cataplexy; Dogs; Female; Fluoxetine; Hal | 1981 |
Synergistic potentiation of halopoderidol-induced catalepsy by gamma-butyrolactone.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cataplexy; Dopamine; Dose-Response Relationship, Drug; Drug | 1976 |
Persisting psychotic states in adolescent drug users.
Topics: Adolescent; Cataplexy; Child, Institutionalized; Chlorpromazine; Delusions; Hallucinations; Hallucin | 1974 |